- Do you own shares of ViroPharma Incorporated (NASDAQ GS: VPHM )?
- Did you purchase any of your shares prior to November 11, 2013?
- Do you think the proposed buyout price is too low?
- Do you want to discuss your rights?
The Dax rose following a strong performance from the automotive sector, but both London and Paris slumped.
Current drugs approved to prevent and reduce the frequency of HAE swelling attacks require injections, so BioCryst's once-daily pill has the potential to be more convenient.
Also up early Thursday: Bellicum and Novocure.